Pyoderma gangrenosum

Phillip J. Eichhorn

Research output: Contribution to journalReview article

13 Scopus citations

Abstract

Pyoderma gangrenosum (PG) is a chronic ulcerative skin disease with striking clinical features that may rarely involve internal organs, particularly the lung, liver, and spleen. Approximately 50% of PG patients have associated inflammatory, immune dysfunction, or neoplastic diseases. The various topical, systemic, and surgical treatment options for PG are reviewed here. Systemic corticosteroids plus immunosuppressive therapy are often required to successfully manage severe cases of PG. Practical treatment strategies are discussed along with their proper monitoring and potential adverse effects. Current treatment methods are empiric, and the optimum treatment regimen for this disorder requires future controlled clinical trials.

Original languageEnglish (US)
Pages (from-to)102-110
Number of pages9
JournalDermatologic Therapy
Volume14
Issue number2
DOIs
StatePublished - Jun 23 2001

    Fingerprint

Keywords

  • Cyclophosphamide
  • Cyclosporine A
  • Mycophenolate mofetil
  • Pyoderma gangrenosum
  • Systemic corticosteroids

ASJC Scopus subject areas

  • Dermatology

Cite this